Ameliorating neural excitotoxicity with memantine [36] and inhibiting neuroinflammation with a PPAR agonist [37] have been shown to successfully prevent cognitive dysfunction, and BBB disruption can predict cognitive impairments [8]. The gene discussed is PPARA; the disease is Cognitive impairment.